NCT06381206

Silodosin in Management of Lower Ureteral Stones

The Use of Selective Alpha Blockers (Silodosin) in Management of Lower Ureteral Stones Larger Than 6 mm in Diameter

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Syrian Private University · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.

Conditions

• Stone, Kidney

Interventions

Type	Name	Description
DRUG	Silodosin	Selective Alpha Blocker drug

Timeline

• Start date: 2022-10-20
• Primary completion: 2023-10-20
• Completion: 2023-10-25
• First posted: 2024-04-24
• Last updated: 2024-04-24

Locations

1 site across 1 country: Syria